Related Experiment Video

Updated: Jun 21, 2025

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
05:06

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Published on: January 5, 2024

580

Unveiling the Secrets of Acinetobacter baumannii: Resistance, Current Treatments, and Future Innovations

Andrea Marino1, Egle Augello2,3, Stefano Stracquadanio4

  • 1Unit of Infectious Diseases, Department of Clinical and Experimental Medicine, University of Catania, ARNAS Garibaldi Hospital, 95122 Catania, Italy.

International Journal of Molecular Sciences
|July 13, 2024
PubMed

Insights

Acinetobacter baumannii infections are a growing threat in hospitals due to increasing antibiotic resistance. New therapies, including novel drugs and phage therapy, are crucial for combating this resilient pathogen.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Acinetobacter baumannii is a major cause of hospital-acquired infections, especially in critically ill patients.
  • This pathogen exhibits significant genomic plasticity, leading to rapid development of resistance to existing antibiotics, including carbapenems.
  • Increasing antimicrobial resistance necessitates urgent identification of novel therapeutic and infection control strategies.

Purpose of the Study:

  • To review current challenges in managing Acinetobacter baumannii infections.
  • To highlight emerging therapeutic approaches and infection control strategies.
  • To emphasize the need for a deeper understanding of A. baumannii's resistance mechanisms.

Main Methods:

  • Literature review of antimicrobial resistance mechanisms in Acinetobacter baumannii.
  • Analysis of novel therapeutic agents and strategies under investigation.
  • Exploration of complementary approaches like phage therapy and AI.

Main Results:

  • Existing antibiotics are losing efficacy against Acinetobacter baumannii due to evolving resistance.
  • Several promising new therapeutic agents are under investigation, including combination therapies (sulbactam/durlobactam, cefepime/zidebactam, imipenem/funobactam) and novel molecules (polymyxins, zosurabalpin).
  • Phage therapy, deep learning, and artificial intelligence offer potential complementary strategies.

Conclusions:

  • A coordinated global response is required to combat the public health threat posed by Acinetobacter baumannii.
  • Understanding molecular mechanisms of resistance is key to developing effective treatments.
  • Novel therapeutic strategies are essential to overcome current treatment limitations.
Keywords:
Acinetobacter baumanniiAcinetobacter infectionsAcinetobacter treatmentsCRABMDR Acinetobactercefiderocoleravacycline

More Related Videos

Author Spotlight: A Comprehensive Protocol for Acinetobacter Biofilm Quantification, Assessment, and Visualization07:41

Author Spotlight: A Comprehensive Protocol for Acinetobacter Biofilm Quantification, Assessment, and Visualization

Published on: August 4, 2023

3.3K
In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging09:29

In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging

Published on: April 28, 2017

9.3K

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
317
Antibiotic Selection00:57

Antibiotic Selection

Overview
53.0K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.8K